Heparin and heparin-like molecules inhibit the Alzheimer's β-secretase (BACE1) : considerations for biological assay and future therapeutic development
The biologically and medically important heparan sulphate and heparin polysaccharides have previously been shown to modulate the activity of an aspartyl protease, β-secretase (BACE1), implicated in the aetiology of Alzheimer’s disease. Research groups investigating the activity of heparin with BACE1...
Main Author: | Hadfield, Lynsay Claire |
---|---|
Published: |
Keele University
2018
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.745337 |
Similar Items
-
The Alzheimer's disease β-secretase enzyme, BACE1
by: Vassar Robert, et al.
Published: (2007-11-01) -
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
by: Miguel A. Maia, et al.
Published: (2019-03-01) -
Analysis of fibroblast growth factor-heparin interactions
by: Xu, Ruoyan
Published: (2012) -
Glycosaminoglycans from <i>Litopenaeus vannamei</i> Inhibit the Alzheimer’s Disease β Secretase, BACE1
by: Courtney J. Mycroft-West, et al.
Published: (2021-04-01) -
Reconstituting APP and BACE in proteoliposomes to characterize lipid requirements for β-secretase activity
by: Kalvodova, Lucie
Published: (2006)